80th Heidelberg Grand Round - Developmental Signatures and Molecular Plasticity in Cancer

Thursday 14 Nov 2024, 16:00 → 18:00 Europe/Berlin

Kommunikationszentrum (Lecture Hall) (German Cancer Research Center (DKFZ))

The NCT Heidelberg invites to the 80th Heidelberg Grand Round - Developmental Signatures and Molecular Plasticity in Cancer. We look forward to welcoming you to the event.

The event will take place on November 14, 2024, from 4:00 PM to 6:00 PM at the DKFZ Communication Center, Im Neuenheimer Feld 280, 69120 Heidelberg.

Please register by November 13, 2024, at the latest. The event is free of charge. 

For the 80th Heidelberg Grand Round, two points for continuing education will be given by the Landesärztekammer. For DKFZ PhD students, attendance of five Grand Rounds will be awarded with one credit point, please use the certificate of attendance issued by the Landesärztekammer for verification.

The NCT Heidelberg is a joint venture of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), the Heidelberg Faculty of Medicine and the Heidelberg Thoracic Clinic. 

Organizer: Heidelberg University Hospital (UKHD)
Event language: English

 

---

Sponsors:

New England Biolabs GmbH - 750 EUR

Active Motif - 500 EUR

 

 

NCT_HGR-80(Flyer)_final.pdf

1 Chair, Introduction

Speakers: Daniel Lipka (National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)), Lena Kutscher (German Cancer Research Center (DKFZ), Hopp Children’s Cancer Center (KiTZ))

2 Neuroblastoma as a Model for Developmental Origins in Childhood Malignancies

Speaker: Frank Westermann (German Cancer Research Center (DKFZ))

3 Mouse Models to Study Developmental Origins of Infant Leukemia

Speaker: Katrin Ottersbach (University of Edinburgh)

4 Developmental Stage-Specific Interplay of Transcriptional Regulators Leading to Childhood Leukemia

Speaker: Jan-Henning Klusmann (Goethe University Frankfurt, German Cancer Consortium (DKTK))

5 Oncofetal Reprogramming Drives Molecular Plasticity in Pediatric Leukemia

Speaker: Mark Hartmann (National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ))

6 Chairs: Conclusion

Speakers: Daniel Lipka (National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)), Lena Kutscher (German Cancer Research Center (DKFZ), Hopp Children’s Cancer Center (KiTZ))